???We are pleased that the core value of POTELLIGENT Technology has been recognized by a global pharmaceutical company such as Pfizer, and are excited to work together with Pfizer on their innovative antibody research pipelines.??? said Yasunori Yamaguchi, Ph.D., president and chief executive officer of BioWa.